In this episode of Healthcare on the Rocks: Employee Benefits with a Twist, Rob Lehane, co-founder and CEO of Leap Health, explores the financial and logistical challenges of specialty infusion therapies—a critical yet often misunderstood aspect of employee healthcare. Drawing on his extensive experience in healthcare and benefits innovation, Rob highlights how Leap Health is transforming the landscape with a focus on cost-saving and patient-centered solutions.
Rob explains that specialty infusion drugs account for a small percentage of employee use but drive disproportionately high healthcare costs.
He shares, "Over half of the specialty drug spend comes from just 2% of employees using infusion therapies."
Leap Health addresses this imbalance by moving care from expensive hospital settings to patient homes, making treatments not only more cost-effective but also far more convenient.
The episode unpacks Leap Health’s transparent pricing model, which eliminates drug markups and aligns care delivery with the needs of both employers and employees.
Key Takeaways From the Episode Include:
- Specialty infusion drugs are a major cost driver, often due to inefficient care settings.
- Leap Health’s in-home infusion model provides a safer, more convenient alternative to hospital-based care.
- Transparent pricing eliminates unnecessary markups, saving employers significant costs.
- Employers can take actionable steps, like exploring site-of-care strategies and direct provider contracts, to better control infusion therapy expenses.
- Supporting employees with chronic conditions enhances productivity, satisfaction, and overall health outcomes.
Stay in Touch!
- Connect with Rob Lehane on LinkedIn
- Visit Leap Health
- Explore the Springbuk Activate Partner Marketplace
- Connect with our co-hosts Brittany Hardaway and Rachael Baumgartner
%20(2).jpg)
